Exclusive: PBM trade group sues Arkansas over pharmacy law
The trade group representing pharmacy benefit managers sued on Monday to overturn a first-in-the-nation state law that prevents them from owning pharmacies in Arkansas.
Why it matters: The Pharmaceutical Care Management Association's lawsuit adds to legal challenges to the ownership ban and comes as other states consider similar policies that blame large drug-price middlemen for rising pharmaceutical prices.
Navitus Health Solutions, a PBM that's not a member of the trade association, is also a plaintiff in the lawsuit.
CVS Health and Cigna, two of the largest PBMs, have filed their own complaints against the law.
What they're saying: The law "will disrupt the way patients, especially patients with very complex medical conditions, receive their medication, and it will require consumers in Arkansas to find new pharmacies," said Katie Payne, senior vice president of public affairs and head of advocacy at PCMA.
More than 40 retail pharmacies in Arkansas that together fill millions of prescriptions each year will have to cease operation under the law, according to the complaint.
Payne said that the law will worsen drug affordability in the state by prohibiting out-of-state companies from running pharmacies that offer lower-cost options.
However, PCMA did not have projections on how Arkansas's law will affect drug prices in the state.
Zoom in: The lawsuit claims that Arkansas's policy gives preferential treatment to pharmacies based in the state, violating the Constitution's dormant Commerce Clause and Privileges and Immunities Clause. It also says the law improperly declares PBMs guilty of antitrust violations and delivers punishment without a trial.
"Rather than innovating and attempting to compete with PBM pharmacies on the merits, many independent pharmacies have turned to state lawmakers to manipulate the market with the heavy hand of government, to artificially tip the scales of competition in their favor," the complaint alleges.
Arkansas Gov. Sarah Huckabee Sanders (R) has said the law is necessary to hold PBMs accountable for anticompetitive actions.
Lawmakers at the state and federal level are increasingly questioning large pharmacy benefit managers like CVS Caremark, Express Scripts and Optum Rx's outsize role in the pharmaceutical supply chain and whether they're contributing to high drug prices.
Between the lines: PCMA's complaint notes that an earlier version of the bill would have required Walmart — Arkansas's largest company — to close its pharmacies as well, since the company administers its own pharmacy benefits for employees.
State legislators amended the policy before it was passed so Walmart would no longer be subject to the law.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. A heated debate over the U.S. healthcare system erupted on X, pitting billionaire entrepreneur Mark Cuban against Sen. Elizabeth Warren (D-Mass) over the root causes of soaring drug prices. What Happened: The clash, unfolding as of Friday, has reignited discussions on Pharmacy Benefit Managers (PBMs) and Big Pharma's tax practices, with the Senate poised to address reform amid rising public scrutiny. Enter Cuban, the Dallas Mavericks owner and founder of Cost Plus Drugs, who fired back with a pointed correction. Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — In a post quoting Warren, Cuban argued that PBMs—not Big Pharma—are the true culprits behind inflated drug prices. 'PBMs corrupt healthcare,' he wrote, explaining that these intermediaries control formularies and manipulate prices to maximize rebate revenue, with three major PBMs negotiating over 90% of rebates for commercial insurance plans. Warren, in her post, had blamed pharmaceutical giants like Johnson & Johnson (NYSE:JNJ) and Pfizer Inc. (NYSE:PFE) for charging Americans the 'highest drug prices in the world' while paying 'zero dollars in federal taxes.' Citing data from her Senate Finance Committee role, Warren highlighted how these companies, alongside AbbVie Inc. (NYSE:ABBV), Amgen Inc. (NASDAQ:AMGN), and Merck & Co Inc. (NYSE:MRK), have exploited tax loopholes from the 2017 Tax Cuts and Jobs Act to shield billions in profits. 'Republicans want to make it worse. I'm fighting back,' she declared, sharing a CNBC headline and urging action against what she calls a 'rigged tax system.' Why It Matters: Cuban has been a critic of the healthcare system, saying that it should be simple. According to him, it's become overly complicated by big insurance companies and PBMs. These groups, he says, act as middlemen, controlling not just the costs but also the accessibility of care. He blames PBMs for lack of transparency, inflated specialty drug prices, rebate distortion, formulary restrictions, and 'Sh–ing on' on independent pharmacies. Some significant firms engaged in the PBM business listed in the U.S. include;Stocks YTD Performance One Year Performance CVS Health Corp. (NYSE:CVS) 51.15% 9.57% Cigna Group. (NYSE:CI) 14.54% -6.95% UnitedHealth Group Inc. (NYSE:UNH) -39.11% -36.60% Meanwhile, here is how some pharmaceutical sector ETFs have performed;Pharma ETFs YTD Performance One Year Performance VanEck Pharmaceutical ETF (NASDAQ:PPH) 1.69% -4.48% iShares US Pharmaceuticals ETF (NYSE:IHE) -0.49% -1.85% Invesco Pharmaceuticals ETF (NYSE:PJP) -3.23% -1.64% SPDR S&P Pharmaceuticals ETF (NYSE:XPH) -4.06% 2.61% KraneShares MSCI All China Health Care Index ETF (NYSE:KURE) 20.55% 22.94% First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) -5.44% -6.27% Direxion Daily Pharmaceutical & Medical (NYSE:PILL) -23.49% -14.63% The SPDR S&P 500 ETF Trust (NYSE:SPY) and Invesco QQQ Trust ETF (NASDAQ:QQQ), which track the S&P 500 index and Nasdaq 100 index, respectively, were mixed in premarket on Friday. The SPY was down 0.30% at $595.67, while the QQQ was 0.015% higher at $529.07, according to Benzinga Pro data. Read Next: Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. Back a bold new approach to cancer treatment with high-growth potential. If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it? Photo courtesy: Shutterstock This article Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' originally appeared on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
San Francisco Chronicle
5 hours ago
- San Francisco Chronicle
What to know about activist Mahmoud Khalil and his release from immigration detention
A Palestinian activist who participated in protests against Israel has been freed from federal immigration detention after 104 days. Mahmoud Khalil, who became a symbol of President Donald Trump 's clampdown on campus protests, left a federal facility in Louisiana on Friday. The former Columbia University graduate student is expected to head to New York to reunite with his U.S. citizen wife and infant son, born while Khalil was detained. Here's a look at what has happened so far in Khalil's legal battle: The arrest Federal immigration agents detained Khalil on March 8, the first arrest under Trump's crackdown on students who joined campus protests against Israel's devastating war in Gaza. Khalil, a legal U.S. resident, was then taken to an immigration detention center in Jena, a remote part of Louisiana thousands of miles from his attorneys and his wife. The 30-year-old international affairs student had served as a negotiator and spokesperson for student activists at Columbia University who took over a campus lawn to protest the war. The university brought police in to dismantle the encampment after a small group of protesters seized an administration building. Khalil was not accused of participating in the building occupation and wasn't among those arrested in connection with the demonstrations. But images of his maskless face at protests, along with his willingness to share his name with reporters, made him an object of scorn among those who saw the protesters and their demands as antisemitic. The legal fight Khalil wasn't accused of breaking any laws during the protests at Columbia. However, the government has said noncitizens who participate in such demonstrations should be expelled from the U.S. for expressing views the administration considers to be antisemitic and 'pro-Hamas,' referring to the Palestinian militant group that attacked Israel on Oct. 7, 2023. Khalil's lawyers challenged the legality of his detention, arguing that the Trump administration was trying to deport him for an activity protected by the First Amendment of the U.S. Constitution. U.S. Secretary of State Marco Rubio justified Khalil's deportation by citing a rarely used statute that gives him power to deport those who pose 'potentially serious adverse foreign policy consequences for the United States.' The initial ruling Immigration Judge Jamee E. Comans ruled in April that the government's contention was enough to satisfy requirements for Khalil's deportation. Comans said the government had 'established by clear and convincing evidence that he is removable.' Federal judges in New York and New Jersey had previously ordered the U.S. government not to deport Khalil while his case played out in court. Khalil remained detained for several weeks, with his lawyers arguing that he was being prevented from exercising his free speech and due process rights despite no obvious reason for his continued detention. Release granted Khalil was released after U.S. District Judge Michael Farbiarz said it would be 'highly, highly unusual' for the government to continue detaining a legal U.S. resident who was unlikely to flee and hadn't been accused of any violence. 'Petitioner is not a flight risk, and the evidence presented is that he is not a danger to the community,' he said. 'Period, full stop.' During an hourlong hearing conducted by phone, the New Jersey-based judge said the government had 'clearly not met' the standards for detention. Speaking Friday outside the detention facility, Khalil said, 'Justice prevailed, but it's very long overdue. This shouldn't have taken three months.' Legal fight continues The government filed notice Friday evening that it's appealing Khalil's release. The Department of Homeland Security said in a post on the social platform X that the same day Farbiarz ordered Khalil's release, an immigration judge in Louisiana denied Khalil bond and 'ordered him removed.' That decision was made by Comans, who is in a court in the same detention facility from which Khalil was released. 'An immigration judge, not a district judge, has the authority to decide if Mr. Khalil should be released or detained,' the post said. Farbiarz ruled that the government can't deport Khalil based on its claims that his presence could undermine foreign policy. But he gave the administration leeway to pursue a potential deportation based on allegations that Khalil lied on his green card application, an accusation Khalil disputes. Khalil had to surrender his passport and can't travel internationally, but he will get his green card back and be given official documents permitting limited travel within the U.S., including New York and Michigan to visit family, New Jersey and Louisiana for court appearances and Washington to lobby Congress. Khalil said Friday that no one should be detained for protesting Israel's war in Gaza. He said his time in the Jena, Louisiana, detention facility had shown him 'a different reality about this country that supposedly champions human rights and liberty and justice.' In a statement after the judge's ruling, Khalil's wife, Dr. Noor Abdalla, said she could finally 'breathe a sigh of relief' after her husband's three months in detention. The judge's decision came after several other scholars targeted for their activism have been released from custody, including another former Palestinian student at Columbia, Mohsen Mahdawi; a Tufts University student, Rumeysa Ozturk; and a Georgetown University scholar, Badar Khan Suri.
Yahoo
7 hours ago
- Yahoo
House Democrat: We should be let into ICE facilities
Rep. Gregory Meeks (D-N.Y.) condemned new policies Friday requiring prescreening for lawmakers' visits to immigration detention facilities after a series of incidents where members of Congress seeking to conduct oversight were denied entry. 'This administration has continuously tried to go around Congress and block Congress from doing its constitutionally responsible duties,' Meeks said during a Friday appearance on MSNBC. 'We are and have oversight and should be let into these facilities without notice,' he added. Meeks said Department of Homeland Security (DHS) officials can misrepresent conditions when provided advanced notice of oversight visits. His comments come after the DHS issued new guidance requesting 72-hour notice before members of Congress visit facilities. Several lawmakers in New Jersey, California, Illinois and New York have been barred from entering facilities to conduct legal oversight. Meeks said the DHS's new policy is 'problematic.' 'The way that you find out what actually is taking place, and we've done this under several administrations, Democrat and Republican previously, you're able to walk in and make an assessment of what is and what is not taking place,' Meeks told MSNBC. 'When you are prevented from doing your job and prevented from, you know, doing what the Constitution says you should be doing, then it makes you feel that there is something going on that should not be going on.' Multiple detainees have complained of overcrowding and a lack of due process amid national protests regarding the Trump administration's new immigration policies. Rep. Bennie Thompson (D-Miss.) also said Homeland Security Secretary Kristi Noem is seeking to block lawmakers from visiting Immigration and Customs Enforcement (ICE) field offices, even during advance visits. 'No matter how much she and Trump want to force us to live under their authoritarian rule, ICE is not above oversight and the Department must follow the law. This unlawful policy is a smokescreen to deny Member visits to ICE offices across the country, which are holding migrants – and sometimes even U.S. citizens – for days at a time,' Thompson, ranking member of the House Homeland Security Committee, said in a statement. 'They are therefore detention facilities and are subject to oversight and inspection at any time. DHS pretending otherwise is simply their latest lie. There is no valid or legal reason for denying Member access to ICE facilities and DHS's ever-changing justifications prove this,' he added. DHS Assistant Secretary Tricia McLaughlin said in a statement to The Hill, 'As ICE law enforcement have seen a surge in assaults, disruptions and obstructions to enforcement, including by politicians themselves, any requests to tour processing centers and field offices must be approved by the Secretary of Homeland Security. These requests must be part of legitimate congressional oversight activities.'As for visits to detention facilities, requests should be made with sufficient time to prevent interference with the President's Article II authority to oversee executive department functions—a week is sufficient to ensure no intrusion on the President's constitutional authority. To protect the President's Article II authority, any request to shorten that time must be approved by the Secretary.' Updated at 6:36 p.m. EDT. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
